Secor Capital Advisors’s Surmodics SRDX Stock Holding History

Secor Capital Advisors’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,331	Closed	-$205K	–	567
2018 Q4	$205K	Sell	4,331 -1,851	-30%	-$111K	0.03%	414
2018 Q3	$461K	Buy	+6,182	New	+$426K	0.05%	326
2017 Q4	–	Sell	-7,240	Closed	-$224K	–	586
2017 Q3	$224K	Sell	7,240 -380	-5%	-$10.3K	0.02%	401
2017 Q2	$215K	Buy	+7,620	New	+$184K	0.02%	422
2017 Q1	–	Sell	-10,837	Closed	-$275K	–	597
2016 Q4	$275K	Sell	10,837 -1,290	-11%	-$33.9K	0.03%	414
2016 Q3	$365K	Sell	12,127 -11,928	-50%	-$328K	0.04%	412
2016 Q2	$565K	Sell	24,055 -868	-3%	-$19K	0.07%	365
2016 Q1	$459K	Buy	24,923 +12,416	+99%	+$234K	0.06%	345
2015 Q4	$254K	Buy	+12,507	New	+$266K	0.07%	421
2015 Q1	–	Sell	-14,332	Closed	-$317K	–	536
2014 Q4	$317K	Buy	+14,332	New	+$304K	0.13%	260

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Secor Capital Advisors's SRDX Position: Q1 2019 in Review

Secor Capital Advisors sold out of Surmodics (SRDX) in Q1 2019, closing a stake of 4,331 shares — an estimated $205K sold.

Secor Capital Advisors first reported a position in SRDX in Q4 2014 and held it in 10 quarters. The position peaked at $565K in Q2 2016. 151 funds tracked by Wall St. Rank hold SRDX as of Q1 2019.

Secor Capital Advisors reported no remaining Surmodics position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 4,331 Surmodics shares in Q1 2019, an estimated $205K.
Secor Capital Advisors first reported a position in Surmodics in Q4 2014 and held it in 10 quarters.
Secor Capital Advisors's Surmodics position peaked at $565K in Q2 2016.
151 funds tracked by Wall St. Rank held Surmodics as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.